AJP - Gastrointestinal and Liver Physiology, Vol 269, Issue 6 902-G912, Copyright © 1995 by American Physiological Society

ARTICLES

Extracellular matrix incorporation of normal and NEM-alkylated fibronectin: liver and spleen deposition

R. A. Rebres, P. J. McKeown-Longo, P. A. Vincent, E. Cho and T. M. Saba
Department of Physiology and Cell Biology, Albany Medical College, New York 12208, USA.

The incorporation of plasma fibronectin (pFn) into the extracellular matrix (ECM) is believed to influence tissue integrity, wound repair, and vascular permeability. In vitro, matrix assembly of Fn requires the binding of soluble Fn to cell-associated matrix assembly sites. Alkylation of human pFn (HFn) with N-ethylmaleimide (NEM) prevents the initial binding of Fn to matrix assembly sites as well as its in vitro incorporation into the ECM as reflected by detergent-insoluble 125I-labeled Fn (pool II Fn). We determined the kinetics of Fn matrix incorporation in tissue and whether NEM treatment of rat pFn (NEM-RFn) would limit its in vivo incorporation into ECM by analysis of pool I [deoxycholate (DOC) soluble] and pool II (DOC insoluble) 125I-Fn in tissues after its intravenous injection into rats. After intravenous injection, tissue incorporation of normal rat 125I-pFn was especially intense in liver and spleen, in agreement with the large amount of endogenous Fn detected in the matrices of these organs. Tissue deposition of plasma-derived 125I-RFn in liver and spleen peaked by 4 h, with significant (P < 0.01) loss over 24 h, indicating turnover of matrix Fn. Tissue localization of normal 125I-RFn in liver, lung, spleen, heart, and intestine was greater (P < 0.05) than 125I-NEM-RFn at 4 h. Normal HFn, but not NEM-HFn, was incorporated into tissues and colocalized with endogenous Fn in the matrix. To identify the cells mediating the intense incorporation of pFn into liver ECM, we compared matrix assembly of 125I-HFn by cultured fibroblasts, hepatocytes, and hepatic Kupffer cells. With fibroblasts, 125I-HFn in pool I reached steady state by 3 h, whereas 125I-HFn in pool II exceeded that in pool I by 6 h and continued to increase over 24 h. With hepatocytes, pool I 125I-HFn reached steady state by 1 h, and a progressive increase (P < 0.05) of 125I-HFn in pool II was observed over 24 h. Kupffer cells were not able to incorporate significant amounts of 125I-HFn into matrix. NEM-HFn displayed limited incorporation into ECM by both fibroblast and hepatocyte cultures. These novel observations suggest that the interaction of soluble pFn with matrix assembly sites is necessary to its in vivo incorporation into the ECM.

This article has been cited by other articles:

				O. M. Martinez-Estrada, L. Manzi, P. Tonetti, E. Dejana, and G. Bazzoni Opposite effects of tumor necrosis factor and soluble fibronectin on junctional adhesion molecule-A in endothelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1081 - L1088. [Abstract] [Full Text] [PDF]

				J. Sottile and D. C. Hocking Fibronectin Polymerization Regulates the Composition and Stability of Extracellular Matrix Fibrils and Cell-Matrix Adhesions Mol. Biol. Cell, October 1, 2002; 13(10): 3546 - 3559. [Abstract] [Full Text] [PDF]

				R. F. Rotundo, T. M. Curtis, M. D. Shah, B. Gao, A. Mastrangelo, S. E. LaFlamme, and T. M. Saba TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L316 - L329. [Abstract] [Full Text] [PDF]

				R. Chen, B. Gao, C. Huang, B. Olsen, R. F. Rotundo, F. Blumenstock, and T. M. Saba Transglutaminase-mediated fibronectin multimerization in lung endothelial matrix in response to TNF-alpha Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L161 - L174. [Abstract] [Full Text] [PDF]

				R. F. Rotundo, P. A. Vincent, P. J. McKeown-Longo, F. A. Blumenstock, and T. M. Saba Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor Am J Physiol Gastrointest Liver Physiol, December 1, 1999; 277(6): G1189 - G1199. [Abstract] [Full Text] [PDF]

				M. Resnikoff, T. Brien, P. A. Vincent, R. F. Rotundo, E. Lewis, P. J. McKeown-Longo, and T. M. Saba Lung matrix incorporation of plasma fibronectin reduces vascular permeability in postsurgical bacteremia Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L749 - L759. [Abstract] [Full Text] [PDF]

				T. M. Curtis, R. F. Rotundo, P. A. Vincent, P. J. McKeown-Longo, and T. M. Saba TNF-alpha -induced matrix Fn disruption and decreased endothelial integrity are independent of Fn proteolysis Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L126 - L138. [Abstract] [Full Text] [PDF]

				T. P. Brien, P. P. Reddy, P. A. Vincent, E. P. Lewis, J. S. Ross, and T. M. Saba Lung matrix deposition of normal and alkylated plasma fibronectin: response to postsurgical sepsis Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L432 - L443. [Abstract] [Full Text] [PDF]